Yon Su Kim
Seoul National University Hospital
468 Papers
1.9K Citations
Yon Su Kim is an academic researcher from Seoul National University Hospital. The author has contributed to research in topics: Medicine & Kidney disease. The author has an hindex of 39, co-authored 464 publications. Previous affiliations of Yon Su Kim include New Generation University College & Seoul National University.
Chat about Author
Papers
Severe hyperkalemia requiring hospitalization: predictors of mortality.
Jung Nam An,Jung Pyo Lee,Jung Pyo Lee,Hee Jung Jeon,Do Hyoung Kim,Yun Kyu Oh,Yun Kyu Oh,Yon Su Kim,Chun Soo Lim,Chun Soo Lim +9 more
TL;DR: A higher in-hospital mortality rate was significantly associated with the presence of cardiac arrest and/or MOF at the time of diagnosis, emergent admission, and intensive care unit treatment during hospitalization, compared with AKI superimposed on CKD.
A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.
Brad H. Rovin,Neil Solomons,William F. Pendergraft,Mary Anne Dooley,James A. Tumlin,Juanita Romero-Diaz,Lidia Lysenko,Sandra V. Navarra,Robert B. Huizinga,Ihar Adzerikho,Elena Mikhailova,Natalya Mitkovskaya,Sergey Pimanov,Nikolay Soroka,Boris Iliev Bogov,Boriana Deliyska,Valentin Ikonomov,Eduard Tilkiyan,Ruth Almeida,Fernando Jimenez,Faud Teran,Irma Tchokhonelidze,Nino Tsiskarishvili,Maynor Herrera Mendez,Nilmo Noel Chavez Perez,Arturo Reyes Loaeza,Sergio Ramon Gutierrez Urena,Juanita Romero Diaz,Rodolfo Araiza Casillas,Magdalena Madero Rovalo,Stanislaw Niemczyk,Antoni Sokalski,Andrzej Wiecek,Marian Klinger,Olga V. Bugrova,Tatiana M. Chernykh,Tatiana R. Kameneva,Lidia Lysenko,Tatiana A. Raskina,Olga V. ReshEtko,Natalia N. Vezikova,Tatiana V. Kropotina,Adelya N. Maksudova,Vyacheslav Marasaev,Vladimir A. Dobronravov,Ivan Gordeev,Ashot M. EssAian,Alexey Frolov,Rosa Jelacic,Dragan Jovanovic,Branka Mitic,Gordana Pekovic,Milan Radovic,Goran Radunovic,Patricia Carreira,Federico Diaz Gonzalez,Xavier Fulladosa,Eduardo Ucar,Shamila De Silva,Chula Herath,Anura Hewageegana,Abdul Latiff Mohamed Nazar,A.W.M. Wazil,Iryna Dudar,Olga Godlevska,Svitlana Korneyeva,ViktoriIa Vasylets,Nataliya Sydor,Mykola Kolesnyk,Samir V. Parikh,Nancy J. Olsen,Ellen M. Ginzler,James A. Tumlin,Amit Saxena,Ramesh Saxena,Richard A. Lafayette,William Franklin Pendergraft,Amber S. Podoll,Annie A. Arrey-Mensah,Michael Bubb,Jennifer Grossman,Alejandro I. Oporta,Alireza Nami,Md. Mujibur Rahman,Syed Atiqul Haq,Tak Mao Chan,Mok Mo Yin Temy,Harold Michael P. Gomez,James Bermas,Bernadette Heizel Reyes,Llewellyn T. Hao,Linda Charmaine Roberto,Eric Amante,Allan E. Lanzon,Jung-Yoon Choe,Tae Young Kang,Yon Su Kim,Seung-Geun Lee,Ji Soo Lee,Jason Choo Chon Jun,Archana Vasudevan,Shue-Fen Luo,Tien-Tsai Cheng,Bancha Satirapoj,Kajohnsak Noppakun +104 more
TL;DR: The AURA-LV study suggests that the addition of low-dose voclosporin to mycophenolate mofetil and corticosteroids for induction therapy of active LN results in a superior renal response compared to myCophenolatemofetIL and cortICosteroids alone, but higher rates of adverse events including death were observed.
265
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis
Jingyuan Xie,Lili Liu,Nikol Mladkova,Yifu Li,Hong Ren,Weiming Wang,Zhao Cui,Zhao Cui,Li Lin,Xiaofan Hu,Xialian Yu,Jing Xu,Gang Liu,Gang Liu,Yasar Caliskan,Carlo Sidore,Olivia Balderes,Raphael J. Rosen,Monica Bodria,Monica Bodria,Francesca Zanoni,Francesca Zanoni,Jun Zhang,Priya Krithivasan,Karla Mehl,Maddalena Marasa,Atlas Khan,Fatih Ozay,Pietro A. Canetta,Andrew S. Bomback,Gerald B. Appel,Simone Sanna-Cherchi,Matthew G. Sampson,Laura H. Mariani,Agnieszka Perkowska-Ptasińska,Magdalena Durlik,Krzysztof Mucha,Krzysztof Mucha,Barbara Moszczuk,Bartosz Foroncewicz,Leszek Pączek,Leszek Pączek,Ireneusz Habura,Elisabet Ars,José Ballarín,Laila Yasmin Mani,Bruno Vogt,Savas Ozturk,Abdulmecit Yildiz,Nurhan Seyahi,Hakki Arikan,Mehmet Koc,Taner Basturk,Gonca E. Karahan,Sebahat Akgul,Mehmet Sukru Sever,Dan Zhang,Domenico Santoro,Mario Bonomini,Francesco Londrino,Loreto Gesualdo,Jana Reiterova,Vladimir Tesar,Claudia Izzi,Silvana Savoldi,Donatella Spotti,Carmelita Marcantoni,Piergiorgio Messa,Marco Galliani,Dario Roccatello,Simona Granata,Gianluigi Zaza,Francesca Lugani,Gian Marco Ghiggeri,Isabella Pisani,Landino Allegri,Ben Sprangers,Jin Ho Park,Belong Cho,Belong Cho,Yon Su Kim,Dong Ki Kim,Hitoshi Suzuki,Antonio Amoroso,Daniel C. Cattran,Fernando C. Fervenza,Antonello Pani,Patrick Hamilton,Shelly Harris,Sanjana Gupta,Chris Cheshire,Stephanie Dufek,Naomi Issler,Ruth J. Pepper,John O. Connolly,Stephen H. Powis,Detlef Bockenhauer,Horia Stanescu,Neil Ashman,Ruth J. F. Loos,Eimear E. Kenny,Eimear E. Kenny,Matthias Wuttke,Kai-Uwe Eckardt,Kai-Uwe Eckardt,Anna Köttgen,Julia M. Hofstra,Marieke J H Coenen,Lambertus A. Kiemeney,Shreeram Akilesh,Matthias Kretzler,Lawrence H. Beck,Bénédicte Stengel,Hanna Debiec,Pierre Ronco,Pierre Ronco,Jack F.M. Wetzels,Magdalena Zoledziewska,Francesco Cucca,Iuliana Ionita-Laza,Hajeong Lee,Elion Hoxha,Rolf A.K. Stahl,Paul Brenchley,Francesco Scolari,Ming hui Zhao,Ali G. Gharavi,Robert Kleta,Nan Chen,Krzysztof Kiryluk +129 more
TL;DR: The findings highlight an unusual genetic architecture of MN, with four loci and their interactions accounting for nearly one-third of the disease risk.
The prevalence of chronic kidney disease (CKD) and the associated factors to CKD in urban Korea: a population-based cross-sectional epidemiologic study.
Suhnggwon Kim,Chun Soo Lim,Chun Soo Lim,Dong Cheol Han,Gyo Sun Kim,Ho Jun Chin,Ho Jun Chin,Seung Jung Kim,Won Yong Cho,Yeong Hoon Kim,Yon Su Kim +10 more
TL;DR: In this paper, the authors survey the prevalence and risk factors for chronic kidney disease (CKD) in Korea using the Modification of Diet in Renal Disease (MDRD) Study equation.
Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice
Keunhee Oh,Hyung Bae Park,Ok Jin Byoun,Dongmyung Shin,Eui Man Jeong,Young Whan Kim,Yon Su Kim,Gerry Melino,In Gyu Kim,Dong Sup Lee +9 more
TL;DR: Inhibition of transglutaminase 2 reduces bleomycin-induced epithelial cell release of interleukin 6 in vitro and pulmonary inflammation and fibrosis in vivo.